Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
Endonovo Therapeutics (ENDV) Stock Price & Analysis
17 Followers
ENDV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume281.84K
Average Volume (3M)N/A
Market Cap
$1.02M
Enterprise Value$1.02M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.2
Beta-1.12
Next Earnings
Jun 17, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding318,751,597
10 Day Avg. Volume400,911
30 Day Avg. VolumeN/A
Standard Deviation0.39
R-Squared0.00298
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.04
Price to Sales (P/S)8.40
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio1.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.07
Enterprise Value/Gross Profit8.14
Enterprise Value/Ebitda-0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Endonovo Therapeutics News
Options Prices
Currently, No data available
---
Ownership Overview
8.41%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
91.59% Public Companies and
Individual Investors
ENDV FAQ
What was Endonovo Therapeutics’s price range in the past 12 months?
Endonovo Therapeutics lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Endonovo Therapeutics’s market cap?
Currently, no data Available
When is Endonovo Therapeutics’s upcoming earnings report date?
Endonovo Therapeutics’s upcoming earnings report date is Jun 17, 2024 which is in 62 days.
How were Endonovo Therapeutics’s earnings last quarter?
Currently, no data Available
Is Endonovo Therapeutics overvalued?
According to Wall Street analysts Endonovo Therapeutics’s price is currently Overvalued.
Does Endonovo Therapeutics pay dividends?
Endonovo Therapeutics does not currently pay dividends.
What is Endonovo Therapeutics’s EPS estimate?
Endonovo Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Endonovo Therapeutics have?
Endonovo Therapeutics has 318,751,600 shares outstanding.
What happened to Endonovo Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Endonovo Therapeutics?
Currently, no hedge funds are holding shares in ENDV
---
Company Description
Endonovo Therapeutics
Endonovo Therapeutics, Inc. engages in developing off bio-electronic approach to regenerative medicine. It focuses on rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.
---
---